Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies.
about
Update on the glomerular filtration barrierLong term metabolic syndrome induced by a high fat high fructose diet leads to minimal renal injury in C57BL/6 miceProteinuria in AMPD2-deficient miceRole of glomerular proteoglycans in IgA nephropathyDisease-dependent mechanisms of albuminuria.Albuminuria and glomerular damage in mice lacking the metabotropic glutamate receptor 1.G-CSF prevents progression of diabetic nephropathy in ratGlomerular proteinuria: a complex interplay between unique players.Correlation of proteinuria with podocyte foot process effacement in IgA nephropathy: an ultrastructural study.p47(phox) contributes to albuminuria and kidney fibrosis in mice.Early-onset diabetic E1-DN mice develop albuminuria and glomerular injury typical of diabetic nephropathy.One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease.Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosisMicroRNA-30 family members regulate calcium/calcineurin signaling in podocytesPodocyte apoptosis is prevented by blocking the Toll-like receptor pathway.Effect of simvastatin on the expression of nephrin, podocin, and vascular endothelial growth factor (VEGF) in podocytes of diabetic rat.What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?Selective loss of podoplanin protein expression accompanies proteinuria and precedes alterations in podocyte morphology in a spontaneous proteinuric rat model.Podocyte Detachment Is Associated with Renal Prognosis in ANCA-Associated Glomerulonephritis: A Retrospective Cohort Study.Genetic Ablation of Calcium-independent Phospholipase A2γ Induces Glomerular Injury in Mice.Astragaloside IV ameliorates renal injury in db/db mice.The glomerular filtration barrier: components and crosstalkRenal albumin filtration: alternative models to the standard physical barriers.Focal segmental glomerulosclerosis: towards a better understanding for the practicing nephrologist.Vps34 deficiency reveals the importance of endocytosis for podocyte homeostasis.Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic RatsStructured illumination microscopy and automatized image processing as a rapid diagnostic tool for podocyte effacement.Requirement for class II phosphoinositide 3-kinase C2alpha in maintenance of glomerular structure and functionUltrastructural changes of podocyte foot processes during the remission phase of minimal change disease of human kidney.Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy.Proteinuria in membranous lupus nephritis: the pathology is in the podocyte.Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy.Autophagy is involved in regulating VEGF during high-glucose-induced podocyte injury.Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized rats.The Incidence of Primary vs Secondary Focal Segmental Glomerulosclerosis: A Clinicopathologic Study.A new low nephron-CKD model with hypertension, progressive decline of renal function and enhanced inflammation in C57BL/6 mice.Metformin ameliorates podocyte damage by restoring renal tissue nephrin expression in type 2 diabetic rats.Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology.
P2860
Q28241692-C10134A5-2000-4625-AF52-CC15ACA61600Q28534010-E2F21A51-65EF-4687-929D-72A7FDB3D224Q28590878-DA6BA24D-1A84-4986-BAC3-32B6BBDD8EA8Q33873668-4214B396-9388-4441-A0E9-EFF9EB322EF2Q34012444-61AEEAAC-BAEB-4333-997C-48B56AA639ABQ34760624-3CB2DF0A-5E4D-4189-893E-D5EEC0BAD835Q35027690-BFBC387E-1D77-4935-8AFF-EF788964B3A8Q35131205-3554DF22-523A-404C-8156-7A59EBE89A19Q35287169-0C4C3A89-EA95-44AE-AB2B-CAD8113D2F09Q35587361-E2F16753-5349-40C4-ACD0-3EE7A7CC6972Q35591301-65BE19DC-64AD-41F2-AB9E-3523F2EEA2F0Q35990846-9508C753-43FE-4E9F-B293-60187CA2F2F5Q36172744-370DB856-3F82-443D-8648-6C02A1BEC046Q36203830-4BDBF3E1-E1C1-40F8-9E04-E7680F83D626Q36266540-20EC100F-A476-4355-8A40-37F09A8881C4Q36346948-3BBD5C17-BEC9-4262-AE2A-B57E66CF070DQ36411779-CDA47D82-107B-46D5-8A01-24AE64E723A1Q36538396-4101A5EB-1FED-48AE-8EEE-B19918FD7CB5Q36778197-A38D213A-640A-4A6F-A4AA-B94730341E7DQ36822354-C7333F40-3D98-4831-B883-017B2E4484AAQ37078637-AFCE27EF-2FAC-4634-AABF-C6AD45EB8ED7Q37227685-E35659CE-B7CE-41A5-9CD3-6B3D3698D4EAQ38039100-096EE087-5596-4FA4-83B7-B5C8242CA584Q38092951-F6827957-1374-4994-BEC7-973428BCAA3CQ38192853-56161EAB-28E8-4919-93D7-C1EFC195F2BEQ40129029-2DA04524-074F-49E7-AE19-C8A3FE8A151EQ41108451-1B9EB929-CFFF-4B1C-8BA4-B5CB0378B237Q41127467-13F8F615-EE91-4D45-8F08-F5023671C122Q42165269-6B316ED0-A674-4FF3-93BD-630BFD11F116Q42456726-391923DD-BBBD-457C-AF4E-882DA2B38BA3Q43059651-8F992C16-BCF2-40A5-9830-A932B6DD162EQ46141201-D8E1EFE0-E511-4004-8E00-2AFC8B5C6DBAQ46442048-1B8BE371-44B6-4AF3-A74B-453AD7424281Q46554485-FE402E89-DAED-4FC9-A61B-8FA90F4DF4CAQ46805054-AFD55B3C-CC2C-46BA-8332-1899E3B314B8Q50127500-EBC50358-283C-46C5-ABAC-FE2446AB45F4Q50141004-FD25DB4A-B490-4BE3-B4E7-917EB65ADF6DQ51726683-23F56BC0-6257-4003-B7A8-C4CF4574723EQ51835187-7D5D5399-7327-41CF-A4DA-891E50E05814Q52609860-5309D43B-33FD-4948-946C-6EE803DBCB2B
P2860
Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Podocyte foot process effaceme ...... ria in human glomerulopathies.
@ast
Podocyte foot process effaceme ...... ria in human glomerulopathies.
@en
type
label
Podocyte foot process effaceme ...... ria in human glomerulopathies.
@ast
Podocyte foot process effaceme ...... ria in human glomerulopathies.
@en
prefLabel
Podocyte foot process effaceme ...... ria in human glomerulopathies.
@ast
Podocyte foot process effaceme ...... ria in human glomerulopathies.
@en
P2093
P1433
P1476
Podocyte foot process effaceme ...... ria in human glomerulopathies.
@en
P2093
Jan J Weening
José G van den Berg
Karel J M Assmann
Marius A van den Bergh Weerman
P304
P356
10.1111/J.1523-1755.2004.00964.X
P407
P577
2004-11-01T00:00:00Z
P5875
P6179
1050638361